Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote (2153)	1/30/1998 1:23:00 AM
From: Mama Bear	Read Replies (3) of 7041

Much has been made of Schering's involvement with Zonagen, and statement such as "Do you really think they didn't do their due diligence" are presented with the hopes that some will infer that ZONA is a can't miss proposition. Yesterday, another partner of Schering's, CORR, took a major hit because their drug wasn't approved for the angina market. While receiving approval for the angioplasty market, this is a much smaller market, and will result in much less revenue. I guess that Schering is not god like in it's assesments of a biotech's potential after all. Barb

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next